Financial Gravity Asset Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Financial Gravity Asset Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$27.21 - $39.48 $108 - $157	-4 Reduced 50.0%	4 $127,000
Q4 2023 Jun 26, 2024	SELL	$21.2 - $31.03 $21 - $31	-1 Reduced 11.11%	8 $244,000
Q3 2023 Nov 15, 2023	SELL	$26.2 - $36.08 $707 - $974	-27 Reduced 75.0%	9 $0
Q2 2023 Aug 08, 2023	BUY	$25.16 - $41.38 $276 - $455	11 Added 44.0%	36 $171,000
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $378 - $616	-16 Reduced 39.02%	25 $196,000
Q4 2022 Feb 15, 2023	SELL	$28.0 - $40.56 $7,168 - $10,383	-256 Reduced 86.2%	41 $182,000
Q3 2022 Nov 03, 2022	SELL	$29.63 - $48.31 $3,644 - $5,942	-123 Reduced 29.29%	297 $256,000
Q2 2022 Aug 05, 2022	SELL	$27.79 - $50.61 $3,668 - $6,680	-132 Reduced 23.91%	420 $272,000
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $12,123 - $21,410	-306 Reduced 35.66%	552 $356,000
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $49,376 - $70,133	850 Added 10625.0%	858 $519,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $467 - $679	8 New	8 $62,000
Q4 2019 Feb 28, 2020	SELL	$28.14 - $73.01 $14,829 - $38,476	-527 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$26.26 - $34.86 $13,839 - $18,371	527 New	527 $15,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.